How often should repetitive transcranial magnetic stimulation (rTMS) be administered and what is the duration of each session?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

rTMS Treatment Frequency and Session Duration

Standard rTMS for treatment-resistant depression consists of up to 30 treatment sessions delivered over approximately 6 weeks, with each session lasting 30-40 minutes and typically administered 5 days per week. 1

Standard Treatment Protocol

Frequency of Administration

  • Daily sessions, 5 days per week (Monday through Friday schedule with weekend breaks) 1
  • Total course: Up to 30 treatment sessions over 6 weeks for treatment-resistant depression 1
  • For other conditions, protocols vary:
    • 15 sessions over 3 consecutive weeks (5 days/week) for schizophrenia negative symptoms 2, 3
    • 10 sessions over 2 consecutive weeks (5 days/week) for chronic migraine 4
    • 6 consecutive daily sessions with monthly booster sessions for Parkinson's disease 5

Session Duration

  • Standard session: 30-40 minutes delivering approximately 1,800 pulses per session 6
  • Shorter alternative: 15 minutes delivering 900 pulses appears equally effective for treatment-resistant depression when given 3 days per week for 6 weeks 6
  • 10-minute sessions (600 pulses in 10 trains) have been used successfully for chronic migraine 4

Key Protocol Parameters

For Treatment-Resistant Depression (Most Common Indication)

  • Location: Left dorsolateral prefrontal cortex 1
  • Frequency: 10 Hz (high-frequency) 2, 3
  • Intensity: 110% of individual motor threshold 2, 3
  • Pulse delivery: Multiple trains with inter-train intervals (e.g., 20 applications of 10-second duration with 30-second intervals) 2

Important Clinical Considerations

Treatment Access Challenges

  • The primary barrier to rTMS is the requirement for frequent onsite visits, which significantly limits access to this treatment modality 1
  • This necessitates careful patient selection for those who can commit to the intensive treatment schedule

Evidence Quality Nuances

  • While aggregate literature supports rTMS benefits for treatment-resistant depression with minimal adverse events, one recent veteran-specific RCT found no significant differences between active rTMS and sham treatment, raising questions about placebo effects from frequent clinical visits 1
  • However, this single study was not considered sufficient to modify the recommendation supporting rTMS use 1

Shorter vs. Longer Sessions

  • 15-minute sessions (900 pulses) 3 days/week were as effective as 30-minute sessions (1,800 pulses) for achieving response and remission in treatment-resistant depression, offering a pragmatic advantage 6
  • This finding suggests flexibility in protocol design to improve treatment accessibility

Maintenance Therapy

  • Some conditions may benefit from booster sessions after the initial treatment course (e.g., monthly 3-day booster sessions for Parkinson's disease maintained therapeutic effects) 5

References

4
Research

Neuronavigation based 10 sessions of repetitive transcranial magnetic stimulation therapy in chronic migraine: an exploratory study.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2021

5
Research

Effect of daily repetitive transcranial magnetic stimulation on motor performance in Parkinson's disease.

Movement disorders : official journal of the Movement Disorder Society, 2006

Related Questions

What is the appropriate management for a patient with a blood pressure of 210/120 mmHg?
What are the five components of the Babinski (extensor plantar) response?
Is a unilateral pulsatile sensation in the ear of a mother who is 1 week postpartum and breastfeeding a normal physiologic finding or does it require further evaluation?
What are the observable seizure manifestations in the 2025 ILAE classification?
What is the appropriate evaluation and management for a 24‑year‑old female presenting with dysuria without burning, normal urine color, and no other symptoms?
What is the recommended algorithm for managing a failed tracheal intubation?
Can a single fertilized ovum produce two gestational sacs?
What does the rash of disseminated gonococcal infection look like?
What are the discharge criteria for a patient with medically managed acute pancreatitis?
Why should losartan be taken in the morning while amlodipine is taken in the evening?
In a patient taking isotretinoin (Accutane) for acne who has thrombocytosis (platelet count ~460 × 10⁹/L) and mild leukocytosis with neutrophilia (white‑cell count ~12 × 10⁹/L, neutrophils ~8 × 10⁹/L), are these platelet and leukocyte abnormalities likely related or unrelated?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.